# Alternation in the Human Microbiome With Commonly Used Topical Medications

> **NCT03437005** · PHASE1 · RECRUITING · sponsor: **University of California, Davis** · enrollment: 24 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Desonide 0.05%
- **DRUG:** Ketoconazole 2%

## Key facts

- **NCT ID:** NCT03437005
- **Lead sponsor:** University of California, Davis
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2013-01-28
- **Primary completion:** 2026-09-28
- **Final completion:** 2026-09-28
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03437005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03437005, "Alternation in the Human Microbiome With Commonly Used Topical Medications". Retrieved via AI Analytics 2026-05-17 from https://api.ai-analytics.org/clinical/NCT03437005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*